Shares of Mesoblast Ltd (MSB.AU) are soaring in the intraday trading session, jumping 5.24% following a significant target price upgrade from Piper Sandler. The surge comes as investors react positively to the increased confidence in the company's potential.

Piper Sandler, a prominent investment bank and financial services company, has raised its target price for Mesoblast from $24 to $35, representing a substantial 46% increase. This bullish outlook from analysts often signals strong confidence in a company's future prospects and can drive increased investor interest.

The considerable target price hike suggests that Piper Sandler sees significant upside potential in Mesoblast's stock. While the specific reasons for the upgrade were not provided in the available news, such revisions are typically based on factors such as improved financial outlook, promising product developments, or positive industry trends. Investors are advised to monitor for any additional information or company announcements that may shed light on the factors behind this optimistic valuation.